Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03500978 · ClinicalTrials.gov registry record · NA

Factors Predicting Ineffective Contraception Use

A NA study of Contraception Behavior, sponsored by Temple University.

Completed
Registry status
NA
Development phase
133
Enrollment target
1
Study location

NCT03500978: Completed NA study of Contraception Behavior, sponsored by Temple University.

NCT03500978 is a NA study of Contraception Behavior that has completed, run by Temple University. The registered enrollment target is 133 participants, below the 853-participant average among 11 other Contraception Behavior trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03500978, a NA study of Contraception Behavior, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
133 participants
Enrollment target
1
Study location

Study Summary

Unintended pregnancy (UP), defined as a mistimed or unwanted pregnancy, is a significant and prevalent public health problem, particularly among low-income women. Over half of all pregnancies are reportedly unintended and UP has been linked to adverse health outcomes in mothers and their children. Correct and consistent use of effective contraception is the primary method to prevent UP. Research has shown that low self-esteem and elevated depressive symptoms increase women's risk for ineffective contraception use and, by extension, for UP. This project examines the feasibility and possible efficacy of reducing ineffective contraception using an intervention that addresses depressive symptoms and self concept among young, low-income, predominantly minority women at risk for UP. Traditional cognitive behavioral therapy (CBT) is effective in reducing depressive symptoms and improving self concept; but limited utilization, poor response, and low adherence to CBT is common among low-income and minority women. A more acceptable method for delivering CBT is needed for the target population. This project will use peer-specialists to deliver a CBT-based intervention to women at risk for UP. Because peer specialists are drawn from the same community as the target population and share some similar life experiences, the intervention may be more acceptable and effective than one offered by trained professionals. This project will examine the effectiveness of a 9 week (8-session) peer-specialist led CBT-based intervention compared to an observational control condition to reduce depressive symptoms, improve self-esteem, and improve consistent contraceptive use to prevent UP. The weekly intervention sessions are delivered by telephone by a trained peer specialist. The study will evaluate the effectiveness of the intervention to improve consistent contraceptive use (primary outcome) and decrease depressive symptoms and increase self-esteem (secondary outcomes).

Primary Outcome

Categorical (yes/no). Self report of using birth control consistently in prior month with a male sexual partner.

Conditions Studied

Interventions

  • BEHAVIORAL Peer CBT Intervention

Study Locations (1)

Pennsylvania

  • Temple University School of Medicine OB/GYN - Philadelphia

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2018-03-19
Est. Completion 2019-05-31
Phase NA
Temple University

163 total trials

What the finished NCT03500978 record still lists

NCT03500978 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 853-participant average among 11 other Contraception Behavior trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Contraception Behavior appearing as the primary indexed condition, and to 1 intervention - of which Peer CBT Intervention is the first listed.

NCT03500978 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03500978 about?

NCT03500978 is a clinical study titled "Factors Predicting Ineffective Contraception Use". Unintended pregnancy (UP), defined as a mistimed or unwanted pregnancy, is a significant and prevalent public health problem, particularly among low-income women. Over half of all pregnancies are reportedly unintended and UP has been linked to adverse health outcomes in mothers and their children. C...

What is the current status of trial NCT03500978?

This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2018-03-19. Estimated completion is 2019-05-31.

What conditions does trial NCT03500978 study?

This clinical trial studies the following conditions: Contraception Behavior.

What interventions are being tested in trial NCT03500978?

The interventions under investigation include: Peer CBT Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03500978?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03500978 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03500978's enrollment target sits among peer trials

133 9th of 11 higher than 3 of 11 other Contraception Behavior trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Contraception Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04276870 · 133 participants · Phase 2

    Orphan Indications for CD19 Redirected Autologous T Cells

  • NCT04671771 · 133 participants · NA

    A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  • NCT05610085 · 133 participants · Phase 2

    A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

  • NCT06206486 · 133 participants

    The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03500978, the US trial registry maintained by the National Library of Medicine. NCT03500978 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.